Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I believe Swartz is out of the picture for the time being...
Well I certainly hope your correct. As we both know PTSC has yet to follow any reasonable calculations relative to our industry P/E ratio. Solid numbers from the Q would be a start but, if ES decides to sell hard into a potential rally what do you think the affect will be on retail shareholders? Hard selling into another historical event for this company will, IMO, be devastating to the S/P for the foreseeable future.
Share
New Message
Please login to post a reply